Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 21, Number 7—July 2015
Research

Monitoring of Ebola Virus Makona Evolution through Establishment of Advanced Genomic Capability in Liberia

Jeffrey R. Kugelman1, Michael R. Wiley1, Suzanne Mate1, Jason T. Ladner1, Brett Beitzel, Lawrence Fakoli, Fahn Taweh, Karla Prieto, Joseph W. Diclaro, Timothy Minogue, Randal J. Schoepp, Kurt E. Schaecher, James Pettitt, Stacey Bateman, Joseph Fair, Jens H. Kuhn, Lisa Hensley, Daniel J. Park, Pardis C. Sabeti, Mariano Sanchez-Lockhart, Fatorma K. Bolay, Gustavo PalaciosComments to Author , and on behalf of US Army Medical Research Institute of Infectious DiseasesNational Institutes of HealthIntegrated Research Facility–Frederick Ebola Response Team 2014–2015
Author affiliations: US Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland, USA (J.R. Kugelman, M.R. Wiley, S. Mate, J.T. Ladner, B. Beitzel, K. Prieto, T. Minogue, R.J. Schoepp, K.E. Schaecher, S. Bateman, M. Sanchez-Lockhart, G. Palacios); Liberian Institute for Biomedical Research, Charlesville, Liberia (L. Fakoli, F. Taweh, F.K. Bolay); Naval Medical Research Unit 3, Cairo, Egypt (J.W. Diclaro); Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick (J. Pettitt, J.H. Kuhn, L. Hensley); Foundation Merieux, Washington, DC, USA (J. Fair); Broad Institute, Cambridge, Massachusetts, USA (D.J. Park, P.C. Sabeti); Center for Systems Biology, Harvard University, Cambridge (P.C. Sabeti)

Main Article

Table 2

Next-generation sequencing of 25 Ebola virus isolates derived from selected patients sampled, Liberia, September 2014–February 2015

Sample ID Coverage, %* No. reads Finishing category† GenBank accession no.
LIBR0093 99.4 169,000 Coding complete KR006947
LIBR0116 97.9 710,168 Coding complete KR006948
LIBR10054 98 2,150,725 Coding complete KR006964
LIBR0073 98.5 3,351,831 Coding complete KR006944
LIBR0503 98.9 3,193,168 Coding complete KR006956
LIBR0286 98.3 1,731,953 Coding complete KR006952
LIBR0993 96.5 750,000 Standard draft KR006960
LIBR0423 97.1 2,676,454 Standard draft KR006954
LIBR0333 97.1 1,775,653 Standard draft KR006953
LIBR10053 98 1,691,652 Standard draft KR006963
LIBR0067 97 2,403,590 Standard draft KR006943
LIBR0092 93.9 2,758,142 Standard draft KR006946
LIBR0090 93.1 1,422,271 Standard draft KR006945
LIBR1413 88.2 2,500,000 Standard draft KR006962
LIBR0058 91.4 1,632,978 Standard draft KR006940
LIBR0176 89.4 1,907,863 Standard draft KR006951
LIBR0168 89.2 1,221,075 Standard draft KR006949
LIBR0505 83.8 741,165 Standard draft KR006957
LIBR1195 73.1 2,200,773 Standard draft KR006961
LIBR0624 68 1,550,511 Standard draft KR006959
LIBR0063 69 2,883,384 Standard draft KR006942
LIBR0173 72.3 1,456,490 Standard draft KR006950
LIBR0059 59.1 851,606 Standard draft KR006941
LIBR0605 64.7 1,587,732 Standard draft KR006958
LIBR0430 56.2 3,139,009 Standard draft KR006955

*Percentage of genome bases (of 18,959 total bases) called in the consensus sequences (requires >3× coverage with base quality >20).
†Categories are defined in (19).

Main Article

References
  1. Baize  S, Pannetier  D, Oestereich  L, Rieger  T, Koivogui  L, Magassouba  N, Emergence of Zaire Ebola virus disease in Guinea—preliminary report. N Engl J Med. 2014;371:141825 . DOIPubMed
  2. Hawkes  N. Ebola outbreak is a public health emergency of international concern, WHO warns. BMJ. 2014;349:g5089. DOIPubMed
  3. Yozwiak  NL, Schaffner  SF, Sabeti  PC. Data sharing: make outbreak research open access. Nature. 2015;518:4779. DOIPubMed
  4. World Health Organization. Ebola situation report—11 March 2015 [cited 2015 Mar 30]. http://apps.who.int/ebola/current-situation/ebola-situation-report-11-march-2015
  5. Chan  M. WHO report by the Director-General to the special session of the Executive Board on Ebola [cited 2015 Mar 30]. http://www.who.int/dg/speeches/2015/executive-board-ebola/en/
  6. Kugelman  JR, Sanchez-Lockhart  M, Andersen  KG, Gire  S, Park  DJ, Sealfon  R, Evaluation of the potential impact of Ebola virus genomic drift on the efficacy of sequence-based candidate therapeutics. MBio. 2015;6:e0222714. DOIPubMed
  7. Shuchman  M. WHO enters new terrain in Ebola research. CMAJ. 2014;186:E5278. DOIPubMed
  8. Sayburn  A. WHO gives go ahead for experimental treatments to be used in Ebola outbreak. BMJ. 2014;349:g5161. DOIPubMed
  9. Trombley  AR, Wachter  L, Garrison  J, Buckley-Beason  VA, Jahrling  J, Hensley  LE, Comprehensive panel of real-time TaqMan polymerase chain reaction assays for detection and absolute quantification of filoviruses, arenaviruses, and New World hantaviruses. Am J Trop Med Hyg. 2010;82:95460. DOIPubMed
  10. Kuhn  JH, Andersen  KG, Baize  S, Bao  Y, Bavari  S, Berthet  N, Nomenclature- and database-compatible names for the two Ebola virus variants that emerged in Guinea and the Democratic Republic of the Congo in 2014. Viruses. 2014;6:476099. DOIPubMed
  11. Djikeng  A, Halpin  R, Kuzmickas  R, Depasse  J, Feldblyum  J, Sengamalay  N, Viral genome sequencing by random priming methods. BMC Genomics. 2008;9:5. DOIPubMed
  12. Gire  SK, Goba  A, Andersen  KG, Sealfon  RS, Park  DJ, Kanneh  L, Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science. 2014;345:136972. DOIPubMed
  13. Martin  M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnetjournal. 2011;17:102.
  14. Schmieder  R, Edwards  R. Quality control and preprocessing of metagenomic datasets. Bioinformatics. 2011;27:8634. DOIPubMed
  15. Li  H, Handsaker  B, Wysoker  A, Fennell  T, Ruan  J, Homer  N, The sequence alignment/map format and SAMtools. Bioinformatics. 2009;25:20789. DOIPubMed
  16. Cingolani  P, Platts  A. Wang le L, Coon M, Nguyen T, Wang L, et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly (Austin). 2012;6:80–92.
  17. Drummond  AJ, Suchard  MA, Xie  D, Rambaut  A. Bayesian phylogenetics with BEAUti and the BEAST 1.7. Mol Biol Evol. 2012;29:196973. DOIPubMed
  18. Guindon  S, Dufayard  JF, Lefort  V, Anisimova  M, Hordijk  W, Gascuel  O. New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst Biol. 2010;59:30721. DOIPubMed
  19. Ladner  JT, Beitzel  B, Chain  PS, Davenport  MG, Donaldson  EF, Frieman  M, Standards for sequencing viral genomes in the era of high-throughput sequencing. MBio. 2014;5:e0136014. DOIPubMed
  20. Geisbert  TW, Lee  AC, Robbins  M, Geisbert  JB, Honko  AN, Sood  V, Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study. Lancet. 2010;375:1896905. DOIPubMed
  21. Warren  TK, Warfield  KL, Wells  J, Swenson  DL, Donner  KS, Van Tongeren  SA, Advanced antisense therapies for postexposure protection against lethal filovirus infections. Nat Med. 2010;16:9914. DOIPubMed
  22. Qiu  X, Audet  J, Wong  G, Fernando  L, Bello  A, Pillet  S, Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb. Sci Rep. 2013;3:3365.
  23. Pettitt  J, Zeitlin  L, Kim  DH, Working  C, Johnson  JC, Bohorov  O, Therapeutic intervention of Ebola virus infection in rhesus macaques with the MB-003 monoclonal antibody cocktail. Sci Transl Med. 2013;5:199ra113. PMID: 23966302
  24. Qiu  X, Wong  G, Audet  J, Bello  A, Fernando  L, Alimonti  JB, Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature. 2014;514:4753 .PubMed
  25. Olinger  GG Jr, Pettitt  J, Kim  D, Working  C, Bohorov  O, Bratcher  B, Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques. Proc Natl Acad Sci U S A. 2012;109:180305. DOIPubMed
  26. Dye  JM, Herbert  AS, Kuehne  AI, Barth  JF, Muhammad  MA, Zak  SE, Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease. Proc Natl Acad Sci U S A. 2012;109:50349. DOIPubMed
  27. Heald  AE, Iversen  PL, Saoud  JB, Sazani  P, Charleston  JS, Axtelle  T, Safety and pharmacokinetic profiles of phosphorodiamidate morpholino oligomers with activity against Ebola virus and Marburg virus: results of two single-ascending-dose studies. Antimicrob Agents Chemother. 2014;58:663947. DOIPubMed
  28. Kuhn  JH, Bao  Y, Bavari  S, Becker  S, Bradfute  S, Brister  JR, Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae. Arch Virol. 2013;158:30111. DOIPubMed
  29. Rezler  JP. Tekmira provides periodic update on TKM-Ebola program [cited 2015 Mar 30]. http://investor.tekmirapharm.com/releasedetail.cfm?ReleaseID=877397
  30. Wilson  JA, Hevey  M, Bakken  R, Guest  S, Bray  M, Schmaljohn  AL, Epitopes involved in antibody-mediated protection from Ebola virus. Science. 2000;287:16646. DOIPubMed
  31. Qiu  X, Alimonti  JB, Melito  PL, Fernando  L, Stroher  U, Jones  SM. Characterization of Zaire ebolavirus glycoprotein-specific monoclonal antibodies. Clin Immunol. 2011;141:21827 . DOIPubMed
  32. Towner  JS, Paragas  J, Dover  JE, Gupta  M, Goldsmith  CS, Huggins  JW, Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening. Virology. 2005;332:207. DOIPubMed
  33. Swenson  DL, Warfield  KL, Warren  TK, Lovejoy  C, Hassinger  JN, Ruthel  G, Chemical modifications of antisense morpholino oligomers enhance their efficacy against Ebola virus infection. Antimicrob Agents Chemother. 2009;53:208999. DOIPubMed
  34. Geisbert  TW, Hensley  LE, Kagan  E, Yu  EZ, Geisbert  JB, Daddario-DiCaprio  K, Postexposure protection of guinea pigs against a lethal Ebola virus challenge is conferred by RNA interference. J Infect Dis. 2006;193:16507. DOIPubMed
  35. Theriault  S, Groseth  A, Neumann  G, Kawaoka  Y, Feldmann  H. Rescue of Ebola virus from cDNA using heterologous support proteins. Virus Res. 2004;106:4350. DOIPubMed
  36. Martínez  MJ, Biedenkopf  N, Volchkova  V, Hartlieb  B, Alazard-Dany  N, Reynard  O, Role of Ebola virus VP30 in transcription reinitiation. J Virol. 2008;82:1256973. DOIPubMed
  37. Biedenkopf  N, Hartlieb  B, Hoenen  T, Becker  S. Phosphorylation of Ebola virus VP30 influences the composition of the viral nucleocapsid complex: impact on viral transcription and replication. J Biol Chem. 2013;288:1116574. DOIPubMed
  38. Carroll  SA, Towner  JS, Sealy  TK, McMullan  LK, Khristova  ML, Burt  FJ, Molecular evolution of viruses of the family Filoviridae based on 97 whole-genome sequences. J Virol. 2013;87:260816. DOIPubMed
  39. World Health Organization. Mali: details of the additional cases of Ebola virus disease [cited 2015 Mar 30]. http://www.who.int/mediacentre/news/ebola/20-november-2014-mali/en/

Main Article

1These authors contributed equally to this article.

Page created: June 12, 2015
Page updated: June 12, 2015
Page reviewed: June 12, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external